Review Series on Multiple Myeloma Update 2025, Guest Editor: Pellegrino Musto
Posted on 2025-01-02Dr. Enrica A. Martino, Dr. G. Mele, Dr. F. Morabito, Dr. M. Gentile, Dr. E. Vigna
Page e2025006 DOI: https://doi.org/10.4084/MJHID.2025.006 PDF HTML
HOW FIRST-LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS
Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda
Page e2025026 PDF HTML DOI: https://doi.org/10.4084/MJHID.2025.026
HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.
Fazio F., Deiana L., Loi C., Mura F., Petrucci M.T., Derudas D.
Page e2025025 PDF HTML DOI: https://doi.org/10.4084/MJHID.2025.025
NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES
Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Antonella Poloni, Massimo Offidani
Page e2025027 PDF HTML DOI: https://doi.org/10.4084/MJHID.2025.027
AN UPDATE OF THE APPROPRIATE SEQUENCING FOR SALVAGE THERAPIES IN MULTIPLE MYELOMA
Gregorio Barila', Francesca Rezzonico, Laura Pavan, Alessandro Corso, Renato Zambello
Page e2025043 DOI: https://doi.org/10.4084/MJHID.2025.043 PDF HTML
BISPECIFIC ANTIBODIES AND CART IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING
Michele Puppi, Ilaria Sacchetti, Katia Mancuso, Paola Tacchetti, Lucia Pantani, ilaria Rizzello, Miriam Iezza, Marco Talarico, Enrica Manzato, Simone Masci, Roberta Restuccia, Simona Barbato, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Elena Zamagni
Page e2025045 DOI: https://doi.org/10.4084/MJHID.2025.045 PDF